Skip to main content

Beckman Coulter's DxA 5000 Lab Automation Solution Receives FDA Clearance

NEW YORK – Beckman Coulter's DxA 5000 total laboratory automation solution received FDA 510(k) clearance and is now available for sale in the US, the company announced today.

The system automatically detects patient tube parameters, including sample identification, tube type, orders pending, and tube weight, within the first three seconds to help eliminate preanalytical errors.

The DxA 5000 with Remisol Advance reduces the manual steps required in sample processing from 32 down to four, Beckman, which is part of Danaher, said in a statement. The solution uses intelligent routing to calculate the quickest and most efficient route for every patient sample, depending on the tests requested, sample volume available, and real-time analyzer capacity and status.

Launched earlier this year in Europe, the system checks the sample volume at three different points and can determine whether there's enough sample to run the ordered test. If multiple tests are ordered, such as a stat and routine test, but there's only enough sample for one, the system will prioritize the stat test.